Polar Capital Holdings PLC Axonics, Inc. Transaction History

Polar Capital Holdings PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$43.74 - $62.76 $839,020 - $1.2 Million	-19,182 Reduced 2.63%	710,336 $44.5 Million
Q4 2021 Feb 14, 2022	BUY	$50.01 - $73.35 $8.4 Million - $12.3 Million	168,002 Added 29.92%	729,518 $40.9 Million
Q2 2021 Aug 16, 2021	SELL	$51.39 - $66.9 $8.45 Million - $11 Million	-164,370 Reduced 22.64%	561,516 $35.6 Million
Q1 2021 May 17, 2021	SELL	$49.14 - $59.89 $8.44 Million - $10.3 Million	-171,803 Reduced 19.14%	725,886 $43.5 Million
Q4 2020 Feb 16, 2021	BUY	$42.19 - $51.5 $37.9 Million - $46.2 Million	897,689 New	897,689 $44.8 Million

209

41.6M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Polar Capital Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Polar Capital Holdings PLC with notifications on news.